Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
Open Access
- 12 May 2022
- journal article
- research article
- Published by Elsevier in World Allergy Organization Journal
- Vol. 15 (6) , 100653
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The mechanisms of smell loss after SARS-CoV-2 infectionThe Lancet Neurology, 2021
- Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensusAllergy, 2021
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7Nature, 2021
- Telemedicine in allergology: practical aspectsAllergo Journal International, 2021
- Telemedicine allows quantitative measuring of olfactory dysfunction in COVID‐19Allergy, 2020
- Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptomsInternational Forum of Allergy & Rhinology, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Anosmia and Ageusia: Common Findings in COVID‐19 PatientsThe Laryngoscope, 2020
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology, 2020
- ‘Sniffin’ Sticks': Olfactory Performance Assessed by the Combined Testing of Odour Identification, Odor Discrimination and Olfactory ThresholdChemical Senses, 1997